These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 8874149)
1. An orally active non-selective endothelin receptor antagonist, bosentan, markedly reduces injury in a rat model of colitis. Hogaboam CM; Muller MJ; Collins SM; Hunt RH Eur J Pharmacol; 1996 Aug; 309(3):261-9. PubMed ID: 8874149 [TBL] [Abstract][Full Text] [Related]
2. Therapeutic effects of the endothelin receptor antagonist Ro 48-5695 in the TNBS/DNBS rat model of colitis. Padol I; Huang JQ; Hogaboam CM; Hunt RH Eur J Gastroenterol Hepatol; 2000 Mar; 12(3):257-65. PubMed ID: 10750644 [TBL] [Abstract][Full Text] [Related]
3. Endothelin-1 is involved in norepinephrine-induced ventricular hypertrophy in vivo. Acute effects of bosentan, an orally active, mixed endothelin ETA and ETB receptor antagonist. Kaddoura S; Firth JD; Boheler KR; Sugden PH; Poole-Wilson PA Circulation; 1996 Jun; 93(11):2068-79. PubMed ID: 8640984 [TBL] [Abstract][Full Text] [Related]
4. Bosentan, an endothelin receptor antagonist, reduces leucocyte adhesion and inflammation in a murine model of inflammatory bowel disease. Anthoni C; Mennigen RB; Rijcken EJ; Laukötter MG; Spiegel HU; Senninger N; Schürmann G; Krieglstein CF Int J Colorectal Dis; 2006 Jul; 21(5):409-18. PubMed ID: 16088386 [TBL] [Abstract][Full Text] [Related]
5. Role of endothelins in trinitrobenzene sulfonic acid-induced colitis in rats. Güllüoglu BM; Kurtel H; Güllüoglu MG; Yegen C; Aktan AO; Dizdaroglu F; Yalin R; Yegen BC Digestion; 1999; 60(5):484-92. PubMed ID: 10473974 [TBL] [Abstract][Full Text] [Related]
6. Effects of the endothelin receptor antagonist Bosentan on ischaemia/reperfusion injury in rat skeletal muscle. Herbert KJ; Hickey MJ; Lepore DA; Knight KR; Morrison WA; Stewart AG Eur J Pharmacol; 2001 Jul; 424(1):59-67. PubMed ID: 11470261 [TBL] [Abstract][Full Text] [Related]
7. Beneficial effects of the endothelin receptor antagonist bosentan on myocardial and endothelial injury following ischaemia/reperfusion in the rat. Li XS; Wang QD; Pernow J Eur J Pharmacol; 1995 Sep; 283(1-3):161-8. PubMed ID: 7498305 [TBL] [Abstract][Full Text] [Related]
8. Anti-ulcerogenic properties of endothelin receptor antagonists in the rat. Padol I; Huang JQ; Hunt RH Aliment Pharmacol Ther; 1999 Apr; 13(4):537-44. PubMed ID: 10215740 [TBL] [Abstract][Full Text] [Related]
9. Role of endogenous endothelin in myocardial and coronary endothelial injury after ischaemia and reperfusion in rats: studies with bosentan, a mixed ETA-ETB antagonist. Richard V; Kaeffer N; Hogie M; Tron C; Blanc T; Thuillez C Br J Pharmacol; 1994 Nov; 113(3):869-76. PubMed ID: 7858879 [TBL] [Abstract][Full Text] [Related]
10. Superoxide dismutase ameliorates TNBS-induced colitis by reducing oxidative stress, adhesion molecule expression, and leukocyte recruitment into the inflamed intestine. Seguí J; Gironella M; Sans M; Granell S; Gil F; Gimeno M; Coronel P; Piqué JM; Panés J J Leukoc Biol; 2004 Sep; 76(3):537-44. PubMed ID: 15197232 [TBL] [Abstract][Full Text] [Related]
11. The effects of endothelin receptor blockade by bosentan on the healing of a bowel anastomosis in an experimental Crohn's disease model. Kirkil C; Cetinkaya Z; Ustundag B; Akpolat N; Ayten R; Bulbuller N J Gastrointest Surg; 2008 Aug; 12(8):1429-35. PubMed ID: 18484142 [TBL] [Abstract][Full Text] [Related]
12. Bosentan antagonizes the effects of endothelin-1 on rat gastric blood flow and mucosal integrity. Lazaratos S; Nakahara A; Goto K; Fukutomi H Life Sci; 1995; 56(9):PL195-200. PubMed ID: 7869843 [TBL] [Abstract][Full Text] [Related]
13. Blood flow alterations in TNBS-induced colitis: role of endothelin receptors. Deniz M; Cetinel S; Kurtel H Inflamm Res; 2004 Jul; 53(7):329-36. PubMed ID: 15241569 [TBL] [Abstract][Full Text] [Related]
14. The endothelin antagonist bosentan does not improve survival in severe experimental pancreatitis in rats. Fiedler F; Ayasse D; Rohmeiss P; Gretz N; Rehbein C; Keim V Int J Pancreatol; 1999 Dec; 26(3):147-54. PubMed ID: 10732291 [TBL] [Abstract][Full Text] [Related]
15. Prevention of cold ischaemia-reperfusion injury by an endothelin receptor antagonist in experimental renal transplantation. Herrero I; Torras J; Riera M; Condom E; Coll O; Cruzado JM; Hueso M; Bover J; Lloberas N; Alsina J; Grinyó JM Nephrol Dial Transplant; 1999 Apr; 14(4):872-80. PubMed ID: 10328462 [TBL] [Abstract][Full Text] [Related]
16. Role of endothelin in fibrosis and anti-fibrotic potential of bosentan. Clozel M; Salloukh H Ann Med; 2005; 37(1):2-12. PubMed ID: 15902842 [TBL] [Abstract][Full Text] [Related]
17. The role of endothelin-1 and endothelin receptor antagonists in allergic rhinitis inflammation: ovalbumin-induced rat model. Tatar A; Yayla M; Kose D; Halici Z; Yoruk O; Polat E Rhinology; 2016 Sep; 54(3):266-72. PubMed ID: 27016898 [TBL] [Abstract][Full Text] [Related]
18. Blockade of endothelin receptors reduces tumor-induced ongoing pain and evoked hypersensitivity in a rat model of facial carcinoma induced pain. Kopruszinski CM; Dos Reis RC; Gambeta E; Acco A; Rae GA; King T; Chichorro JG Eur J Pharmacol; 2018 Jan; 818():132-140. PubMed ID: 29069579 [TBL] [Abstract][Full Text] [Related]
19. Effect of BQ-123 and Ro 47-0203 (bosentan) on endothelin-induced vasoconstriction in the rat skin. Lawrence E; Brain SD Eur J Pharmacol; 1994 Jul; 260(1):103-6. PubMed ID: 7957619 [TBL] [Abstract][Full Text] [Related]
20. Potent anti-inflammatory and antinociceptive activity of the endothelin receptor antagonist bosentan in monoarthritic mice. Imhof AK; Glück L; Gajda M; Bräuer R; Schaible HG; Schulz S Arthritis Res Ther; 2011 Jun; 13(3):R97. PubMed ID: 21689431 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]